MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Net insider $100K over 180 days (1 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $41 avg across 5 analysts.
Buy-rated share 55% → 52% over ~3 months (-2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $0.75 | $0.84 | +12.3% |
| Apr 2026 | $0.71 | $0.68 | -4.8% |
| Feb 2026 | $0.69 | $0.75 | +8.7% |
| Oct 2025 | $0.65 | $0.61 | -6.3% |
| Jul 2025 | $0.65 | $0.66 | +2.3% |
| Apr 2025 | $0.70 | $0.64 | -9.2% |
| Feb 2025 | $0.70 | $0.74 | +5.6% |
| Oct 2024 | $0.66 | $0.65 | -1.5% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $40.8B— | $58.2B+42.6% | $49.7B-14.6% | $56.2B+13.1% | $52.6B-6.4% |
| EPS (dil.) | $2.10— | $2.50+19.0% | $2.52+0.8% | $2.69+6.7% | $2.66-1.1% |
| Free Cash Flow | $6.3B— | $6.1B-3.4% | $4.3B-29.2% | $3.6B-17.0% | $3.0B-17.0% |
| Gross Margin | 14.6% | 11.6%-3.0pp | 13.5%+2.0pp | 12.8%-0.7pp | 13.6%+0.8pp |
| Operating Margin | 15.0% | 11.9%-3.1pp | 13.9%+2.1pp | 13.1%-0.9pp | 13.1%+0.1pp |
| Net Margin | 11.4% | 9.4%-1.9pp | 11.1%+1.7pp | 10.5%-0.6pp | 11.1%+0.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 1.7%/yr (revenue basis).
Base free cash flow $3.6B (avg FY2023–FY2025; latest year $3.0B) · equity value $82.4B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 51 indicates a neutral outlook for EPD, driven by a mix of factors. The stock scores high on value, with a P/E of 13.2 and EV/EBITDA of 10.9, and exhibits low risk, with a beta of 0.5. However, it scores lower on growth and profitability, due to negative revenue and free cash flow growth, as well as moderate return on equity of 21.2%. The long-term and short-term scores are relatively aligned, with the stock's momentum driven by a 21.6% return over the past year, despite a recent 3-month decline.